E. Klieser

2.4k total citations
91 papers, 1.6k citations indexed

About

E. Klieser is a scholar working on Oncology, Psychiatry and Mental health and Surgery. According to data from OpenAlex, E. Klieser has authored 91 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 23 papers in Psychiatry and Mental health and 22 papers in Surgery. Recurrent topics in E. Klieser's work include Schizophrenia research and treatment (14 papers), Histone Deacetylase Inhibitors Research (8 papers) and Gastric Cancer Management and Outcomes (8 papers). E. Klieser is often cited by papers focused on Schizophrenia research and treatment (14 papers), Histone Deacetylase Inhibitors Research (8 papers) and Gastric Cancer Management and Outcomes (8 papers). E. Klieser collaborates with scholars based in Austria, Germany and United States. E. Klieser's co-authors include Daniel Neureiter, Tobias Kiesslich, C. Wurthmann, M.W. Agelink, Roland Geisberger, Kemal Catakovic, E. Lehmann, T Majewski, Tarkan Jäger and Kurt F. J. Heinrich and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

E. Klieser

89 papers receiving 1.6k citations

Peers

E. Klieser
Comparison fields: 5 of 124
  • Oncology 415
  • Molecular Biology 356
  • Psychiatry and Mental health 323
  • Surgery 245
  • Cardiology and Cardiovascular Medicine 202
Katherine M. Sheehan Ireland
Malcolm Whitehead United Kingdom
Kenneth Opeskin Australia
Pascual Medina Spain
Maja Živković Serbia
Jin Zhou China
Jindong Chen China
Yu‐Chiau Shyu Taiwan
Richard T. Lee United States
Leslie J. Sheffield Australia
Katherine M. Sheehan Ireland View profile →
Citations per field, relative to E. Klieser
E. Klieser · 1×
Citations per year, relative to E. Klieser
E. Klieser · 1×

Countries citing papers authored by E. Klieser

Since Specialization
Citations

This map shows the geographic impact of E. Klieser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Klieser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Klieser more than expected).

Fields of papers citing papers by E. Klieser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Klieser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Klieser. The network helps show where E. Klieser may publish in the future.

Co-authorship network of co-authors of E. Klieser

This figure shows the co-authorship network connecting the top 25 collaborators of E. Klieser. A scholar is included among the top collaborators of E. Klieser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Klieser. E. Klieser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy npj Precision Oncology Maxime W. Lafarge, Enric Domingo et al. 9
2 Hydrogen Sulfide Metabolizing Enzymes in the Intestinal Mucosa in Pediatric and Adult Inflammatory Bowel Disease Antioxidants Daniel Weghuber, René G. Feichtinger et al. 13
3 Expression of Oxidative Phosphorylation Complexes and Mitochondrial Mass in Pediatric and Adult Inflammatory Bowel Disease Oxidative Medicine and Cellular Longevity Anna-Maria Schneider, Franz Zimmermann et al. 9
4 Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol Journal of Cancer Research and Clinical Oncology Florian Huemer, Stefan Hecht et al. 7
5 HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer Cancers Christian Mayr, Tobias Kiesslich et al. 22
6 Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrence ESMO Open Teresa Magnes, Aaron R. Thorner et al. 10
7 Changes in the expression of oxidative phosphorylation complexes in the aging intestinal mucosa Experimental Gerontology Franz Zimmermann, René G. Feichtinger et al. 9
8 Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score PLoS ONE Eva Braunwarth, Benno Cardini et al. 32
9 The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer Strahlentherapie und Onkologie Tarkan Jäger, Daniel Neureiter et al. 17
10 The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab The Pharmacogenomics Journal Teresa Magnes, Thomas Melchardt et al. 18
11 Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome Human Pathology E. Klieser, Stefan Stättner et al. 47
12 Differential role of Hedgehog signaling in human pancreatic (patho-) physiology: An up to date review World Journal of Gastrointestinal Pathophysiology E. Klieser, Christian Mayr et al. 18
13 Back to the start: Evaluation of prognostic markers in gastrointestinal stromal tumors Molecular and Clinical Oncology E. Klieser, Ralf Kemmerling et al. 5
14 Experimentelle Untersuchung zu einer Adipositastherapie bei psychopharmakainduziertem Übergewicht Deutsche Zeitschrift für Akupunktur Elke Zimmermann, E. Klieser et al. 1
15 SENSITIVITY OF CARBOHYDRATE-DEFICIENT TRANSFERRIN (CDT) IN RELATION TO AGE AND DURATION OF ABSTINENCE Alcohol and Alcoholism M.W. Agelink, T. Zeit et al. 9
16 Fluoxetine in Patients with Major Depressive Disorder - A Responder Analysis Pharmacopsychiatry E. Klieser, E. Lehmann et al. 17
17 Möglichkeiten der Therapie von Angststörungen des DSM-III-R Fortschritte der Neurologie · Psychiatrie C. Wurthmann, E. Klieser 1
18 The Efficacy of Cavain in Patients Suffering from Anxiety Pharmacopsychiatry E. Lehmann, E. Klieser et al. 10
19 Experimental Examination of Trazodone Clinical Neuropharmacology E. Klieser, E. Lehmann 16
20 Study to Establish the Indication for the Selective S2Antagonist Ritanserin Pharmacopsychiatry E. Klieser, W. Sträub 4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katherine M. Sheehan Breakdown of academic impact, for papers by Malcolm Whitehead Breakdown of academic impact, for papers by Kenneth Opeskin Breakdown of academic impact, for papers by Pascual Medina Breakdown of academic impact, for papers by Maja Živković Breakdown of academic impact, for papers by Jin Zhou Breakdown of academic impact, for papers by Jindong Chen Breakdown of academic impact, for papers by Yu‐Chiau Shyu Breakdown of academic impact, for papers by Richard T. Lee Breakdown of academic impact, for papers by Leslie J. Sheffield
Rankless by CCL
2026